Previous Article | Next Article 
Infection and Immunity, December 2000, p. 6744-6749, Vol. 68, No. 12
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Capsule Impedes Adhesion to and Invasion of
Epithelial Cells by Klebsiella pneumoniae
Hany
Sahly,1,2,*
Rainer
Podschun,1
Tobias A.
Oelschlaeger,3
Michael
Greiwe,1
Haralambos
Parolis,4
David
Hasty,5
Jörn
Kekow,6
Uwe
Ullmann,1
Itzhak
Ofek,2 and
Shlomo
Sela2
Department of Medical Microbiology and
Virology, University of Kiel, Kiel,1
Institut für Molekulare Infektionsbiologie, University of
Würzburg, Würzburg,3 and
Clinic of Rheumatology, University of Magdeburg,
Vogelsang,6 Germany; Department of Human
Microbiology, Sackler Faculty of Medicine, Tel-Aviv University,
Tel-Aviv, Israel2; School of
Pharmaceutical Sciences, Rhodes University, Grahamstown, South
Africa4; and VA Medical Center and
Department of Anatomy and Neurobiology, University of Tennessee,
Memphis, Tennessee5
Received 2 May 2000/Returned for modification 11 July 2000/Accepted 18 September 2000
 |
ABSTRACT |
The adhesion of K21a, K26, K36, and K50 capsulated
Klebsiella strains to ileocecal (HCT-8) and bladder (T24)
epithelial cell lines was significantly lower than that of their
corresponding spontaneous noncapsulated variants K21a/3, K26/1, K36/3,
and K50/3, respectively. Internalization of the bacteria by both
epithelial cell lines was also significantly reduced. Similarly, a
capsule-switched derivative, K2(K36), that exhibited a morphologically
larger K36 capsule and formed more capsular material invaded the
ileocecal epithelial cell line poorly compared to the corresponding K2
parent strain. None of the capsulated strains exhibited
significant mannose-sensitive type 1 fimbriae, whereas two of the
noncapsulated variants K21a/3 and K50/3 exhibited potent
mannose-sensitive hemagglutinating activity. Although hemagglutinating
activity that could be attributed to mannose-resistant
Klebsiella type 3 fimbriae was weak in all strains, in
several cases the encapsulated parent strains exhibited lower
titers than their corresponding noncapsulated variants. Although the
level of adhesion to the ileocecal cells is not different from adhesion
to bladder cells, bacterial internalization by bladder cells was
significantly lower than internalization by ileocecal cells, suggesting
that bladder cells lack components required for the internalization of
Klebsiella.
 |
INTRODUCTION |
Klebsiella pneumoniae is
an opportunistic pathogen involved in outbreaks of nosocomial
infections, such as bacteremia and sepsis, mainly in
immunocompromised individuals (36). Due to the emergence of
multidrug resistance among Klebsiella strains, the
search for new approaches for the prevention or treatment of
Klebsiella infections is now under intensive
investigation (34). To be successful, these efforts will
require a better understanding of the infectious process.
Multiple Klebsiella components (e.g., fimbriae,
siderophores, O antigens, and capsular antigens) have been considered
to be potential virulence factors (34). Of these factors,
capsular antigens are probably considered the major determinants of
pathogenicity (4, 9, 17, 21). As a consequence, new
therapeutic approaches have been targeted against the capsule. A
polysaccharide-based vaccine has been tested (5). Based on
the structural variability of its capsular polysaccharides (CPS),
Klebsiella has been classified into 77 serotypes
(27), which differ markedly in pathogenicity potential and
epidemiological relevance (3, 28, 29, 35). Epidemiological
findings showed that over 70% of all cases of Klebsiella
bacteremia were caused by only 25 of the 77 different serotypes
(6). In clinical studies, this vaccine was proven to be safe
and immunogenic (2, 16). As a potential alternative, it has
been suggested that agents which reduce capsule formation might be used
to enhance phagocytosis and serum killing (10-12).
The primary contribution of CPS to the pathogenicity of
Klebsiella appears to be by rendering the bacteria resistant
to phagocytosis by polymorphonuclear leukocytes and resistant to
killing by serum (30, 33, 38, 39, 41). There are other
capsule-associated activities, however, which might play important
roles in pathogenicity. For instance, it has been shown that
Klebsiella strains expressing CPS containing dimannose or
dirhamnose repeat sequences are recognized by the mannose receptor of
macrophages which bind, ingest, and kill the bacteria (25).
Although K. pneumoniae is considered to be an extracellular
pathogen, recent studies have demonstrated its ability to be
internalized by epithelial cells (20, 24). Recently, the
capsule was shown to interfere with the expression of
Klebsiella adhesins which mediate binding of the bacteria to nonphagocytic cells (19, 22). Because adhesion is important for the internalization process, we sought to determine the role of
capsule in the internalization process of K. pneumoniae,
using capsulated strains, their noncapsulated variants, and a
capsule-switched recombinant strain.
 |
MATERIALS AND METHODS |
Bacterial strains.
All Klebsiella strains used in
this study belonged to the species K. pneumoniae. K. pneumoniae NTCC strains K26 (9146), K36 (9156), and K50 (9170)
were from the strain collection of the Department of Medical
Microbiology and Virology in Kiel. The parent K2 and K21a encapsulated
strains were previously described (26). Spontaneous
noncapsulated variants of serotypes K2, K21a, K26, K50, and K36 were
obtained from nonmucoid segments of colonies of capsulated parent
strains as described elsewhere (22, 37). Likewise, a
revertant capsulated K21a variant was obtained from mucoid segments in
colonies of the noncapsulated K21a strain. The capsule-switched
derivative K2(K36) was constructed as described below. In most
experiments, the bacteria were grown in Luria broth. In the experiments
used to obtain the capsule-switched derivative, M9 medium was
solidified by adding 1% Bacto Agar. Amino acids or antibiotics were
added to allow selection for their auxotrophic, antibiotic-resistant,
capsule-switched derivatives as described previously (26).
Cell lines and culture conditions.
Human bladder epithelial
cell line T24, human ileocecal epithelial cell line HCT-8, and
embryonic intestinal epithelial cell line INT 407 were cultivated as
described by Oelschlaeger and Tall (24). T24 cells were
cultivated in McCoy's 5A medium with 10% fetal calf serum (FCS) and
subcultivated at a ratio of 1:8 twice a week. Human ileocecal
epithelial cell line HCT-8 was cultivated in RPMI 1640 medium with 1 mM
pyruvate, 2 mM glutamine, and 10% FCS, and the INT 407 embryonic
ileocecal cells were cultivated in minimal essential medium containing
10% fetal bovine serum, 2 mM glutamine, and 0.1 mM nonessential amino
acids. Additional human bladder epithelial cells (cell line RT112),
provided by the group of T. F. Meyer, Max-Planck-Institut
für Biologie, Abteilung Infektionsbiologie, Tübingen,
Germany, were used. The cells were cultivated in Waymouth's medium MB
742/1 with 2 mM glutamine and 10% fetal bovine serum.
Genetic manipulation and construction of the capsule-switched
derivative.
The capsule-switched derivative was constructed as
described previously (26). Briefly, we took advantage of the
close proximity of the histidine (his) locus and the CPS
gene cluster, using conversion to his as a marker for the
transfer of the CPS genes from the K36 prototrophic
(his+) donor strain to the his
auxotrophic (his) K2 recipient strain. The donor strain was
also auxotrophic for arginine (arg) and spontaneously nalidixic acid resistant (Nalr). The conjugative plasmid
R68.45, which elicits gene-mobilizing activity, was transferred to the
donor strain from Pseudomonas aeruginosa PAO25(R68.45) as
described previously (26). The CPS genes were transferred by
conjugation from the Nalr his+ donor
strain K36 to the his K2 recipient strain.
his+ Nals colonies were then
selected and tested for expression of the heterologous CPS by the
capsule-swelling method using homologous sera.
Determination, visualization, and analysis of CPS by nuclear
magnetic resonance spectroscopy.
For analysis of CPS, samples were
deuterium exchanged several times by freeze-drying solutions of the
polysaccharide in D2O and were then examined in 99.99%
D2O (0.45 ml) containing a trace of acetone for use as an
internal reference (
2.23 for 1H and 31.07 ppm for
13C). Spectra were recorded at 60°C on a Bruker AMX-400
spectrometer equipped with an X32 computer using standard Bruker
software. The relative molecular weights of polysaccharides were
approximated by molecular sieve chromatography as described previously
(15).
For visualization, we stabilized the capsule using anti-K36 serum and
employed an immunoelectron microscopic technique described previously
(26). Zwittergent extracts of the strains were analyzed for
CPS content by the uronic acid assay of Blumenkranz and Asboe-Hansen (1) as described elsewhere (11).
Bacteriocin typing.
A modification of the scrape-and-point
method was used as described elsewhere (32). Briefly, eight
bacteriocin-producing strains were spot inoculated onto tryptic soy
agar. After growth for 16 h at 32°C and subsequent inactivation
by chloroform vapors, the plates were overlaid with soft tryptic soy
agar containing the strains to be tested. After incubation for 8 h
at 37°C, susceptibility of the test strains to particular
bacteriocins was indicated by a zone of growth inhibition around the spots.
PFGE.
Pulsed-field gel electrophoresis (PFGE) of the
isolates was performed by a modification of the method described by
Weller et al. (40). Briefly, strains were grown in brain
heart infusion broth (BHI) at 37°C with shaking. After harvesting and
washing in TEN buffer (0.1 M Tris, 0.15 M NaCl, 0.1 M EDTA [pH 7.5]), the bacteria were adjusted to 2 × 109 cells/ml. One
milliliter of the bacterial suspension was mixed with 1 ml of 1%
Incert Agarose and poured into a gel plug mold. Plugs were incubated
for at 37°C in EC buffer (6 mM Tris, 1 mM NaCl, 100 mM EDTA, 0.5%
Brij, 0.2% deoxycholate, sodium 0.5% lauroylsarcosine [pH 7.5])
supplemented with lysozyme (1 mg/ml) and RNase (80 µg/ml). After
16 h of incubation, the EC buffer was replaced by ES buffer (0.5 M
EDTA, sodium 1% lauroylsarcosine [pH 9.3]) containing proteinase K
(1 mg/ml). After overnight incubation at 50°C, the plug was washed in
TE buffer (10 mM Tris, 0.1 mM EDTA). The plug was incubated for further
3 h at 37°C after addition of 100 µl of a solution of
phenylmethylsulfonyl fluoride (174 mg/ml) in TE buffer. Finally, the
plug was washed four times with TE buffer and stored at 4°C until use.
Digestion of DNA was performed by overnight incubation of the plug in
the presence of 40 U of the restriction endonuclease
XbaI at
37°C. After extensive washing in TE buffer, the plug was
subjected to
PFGE in an 1% agarose gel containing 1% ethidium
bromide.
Electrophoresis was performed in 0.5× TBE using a CHEF-DR
III system
(Bio-Rad Laboratories). The running conditions were
6 V/cm, 120°C, 60 to 90 s, and 22 h. The gels were photographed
under UV light
at 254 nm using a video documentation
system.
Hemagglutination assay.
The expression of type 1 (mannose-sensitive hemagglutination [MSHA]) and type 3 (mannose-resistant Klebsiella hemagglutination [MR/K-HA])
pili was examined as described previously (31). After four
passages (either serial 48-h passages in static BHI for the detection
of MSHA or passage in nutrient broth for detection of MR/K-HA), the
bacteria were allowed to grow in Luria broth for 2 h before being
harvested and washed three times with phosphate-buffered saline. Then
50 µl of bacterial suspension (3 × 109 cells/ml)
was mixed with 50 µl of guinea pig erythrocytes (5 × 108/ml) for determination of MSHA or with tanned ox
erythrocytes for testing MR/K-HA. Hemagglutination activity was
determined as the minimum bacterial density (expressed as CFU per
milliliter) required to agglutinate erythrocytes. Agglutination was
observed after 3 min of gentle shaking at room temperature and after
another 10 min at 4°C.
Internalization and adhesion assays.
Internalization assays
were performed as described earlier (24). Epithelial cells
were grown in 24-well cell culture clusters to confluent monolayers
(7 × 104 cells per well) in RPMI 1640 medium
supplemented with 10% FCS. Mid-log-phase bacteria (2 × 106; A600 = 0.4 to 0.6) in 0.1 ml of buffer were then added to each well (approximately 30 bacteria
per epithelial cell). After centrifugation at 200 × g
for 5 min, internalization was allowed to occur for 2 h at 37°C
in an atmosphere of 94% air-6% CO2. Before a second 2-h
incubation period under the same conditions but with fresh medium
containing 100 µg of gentamicin per ml, monolayers were washed once
with Earle's balanced salts solution. Under these conditions, all
extracellular (i.e., not internalized) bacteria were killed by the
added gentamicin. The monolayers were then washed twice with Earle's
balanced salt solution and lysed with 0.1% Triton X-100 to determine
the viable counts of released intracellular bacteria. Invasion ability
was expressed as the percentage of inoculum that survived gentamicin
treatment. All assays were conducted in duplicate and were repeated
independently at least five times.
To determine the level of bacterial adhesion, mid-log-phase bacteria
were suspended in FCS-free RPMI 1640 buffer and added
to 24-well plates
containing epithelial cells that had been prewashed
three times with
the same buffer. The plates were then centrifuged
at 200 ×
g for 5 min and further incubated for 30 min at 37°C.
The plates
were then washed three times to remove nonadherent
bacteria, and the
epithelial cells were lysed to enumerate adherent
bacteria as described
above. The lack of internalization in FCS-free
medium after 30 min was
demonstrated by performing a gentamicin
killing assay parallel to the
adhesion assay. No bacterial growth
could be detected during the 30-min
incubation period in the FCS-free
medium.
Assay of intracellular survival and replication.
Following
the invasion period as described above, a medium containing 10 rather
than 100 µg of gentamicin per ml was added to the infected ileocecal
intestinal cells. The transfected cells were incubated at 37°C in 5%
CO2 and lysed at indicated times up to 72 h later by
determination of viable bacteria. The results were recorded as
percentage of the original inoculum.
Statistical analysis.
The significance of differences
between the biological activities of the tested bacteria was evaluated
by the nonparametric analysis of variance test of Kruskal-Wallis
followed by Dunn's posttest.
 |
RESULTS |
Genetic, phenotypic, and serological characterization of the parent
strains, noncapsulated variants, and capsule-switched derivative.
PFGE of DNA was performed to confirm the genetic identity of parents
and their capsule-switched derivative. PFGE patterns of the DNA of the
parental K2 strain and the capsule-switched derivative K2(K36) were
indistinguishable (data not shown). API 20E biochemical reactions,
bacteriocin sensitivity patterns (data not shown), and MSHA and MR/K-HA
activities of the recombinant strain were identical to those of the K2
recipient strain (Table 1). In
contrast, immunoserotyping and nuclear magnetic resonance spectroscopy of CPS showed that the recombinant K2(K36) strain expressed a capsule structurally identical to that of the donor K36
strain.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
MSHA and MR/K-HA by capsulated strains, noncapsulated
variants, and capsule-switched
derivative strainsa
|
|
Identity of the noncapsulated variants to their capsulated parent
strains was assayed by their biochemical reactions (API
20E),
bacteriocin sensitivity patterns, and PFGE. The results
showed that in
all cases the noncapsulated variants were identical
to their parent
strains (data not shown). Likewise, the PFGE and
biochemical properties
of the K21a revertant phase variant strain
KPTA 55 were the same as for
the corresponding parent capsulated
strain (KPTA 20) as well as the
noncapsulated variant K21a/3 from
which it was derived (data not
shown).
The amounts of capsular material produced by the parent strains K21a,
K26, K36, K50, and K2 ranged between 28 and 62 µg of
glucuronic
acid/10
9 bacteria. The noncapsulated strains exhibited up
to 2.2 µg of
glucuronic acid/10
9 bacteria, but had
negative quellung reactions with anticapsular
antibodies,
indicating that these variants are noncapsulated.
The
capsule-switched strain K2(K36) produced 92 µg of glucuronic
acid/10
9 bacteria. Electron microscopic analysis of
antibody-stabilized
capsular material also indicated that the K2(K36)
recombinant
expressed a capsule larger than that of the K36 parent
strain
(Fig.
1). This finding is
consistent with the glucuronic acid
determinations for these two
strains.


View larger version (288K):
[in this window]
[in a new window]
|
FIG. 1.
Immunoelectron micrographs of K2 (A), its
capsule-switched derivative K2(K36) (C), and the parent strain K36 (B)
grown on agar supplemented with 1% lactose and labeled with rabbit
anti-K36 capsule antibody. Note that the anti-K36 serum labeled only
the K36 parent strain and the derivative K2(K36).
|
|
The MSHA and MR/K-HA activities per mass unit of bacteria harvested
after 48 h of growth (four passages) were the same as
those of
bacteria harvested after 2 h of growth in Luria broth
inoculated
with the 48-h-grown bacteria (Table
1). A previous
study showed that
encapsulation may interfere with the assembly
of type 1 fimbrial
subunits into structural fimbriae (
22). Consistent
with this
notion are the results showing that MSHA activity was
very low or
undetectable for all capsulated strains. All of the
noncapsulated
variants derived from K21a and K50 capsulated parent
strains exhibited
potent MSHA activities, suggesting that they
were fully fimbriated
(Table
1). In contrast, the noncapsulated
variants derived from K26 and
K36 parent strains exhibited weak
activity, suggesting that the
majority of the bacterial cells
are nonfimbriated probably
because they are in the off phase (
22).
The minimal
bacterial count required for MR/K-HA activity was
very high
(

3 × 10
9 CFU/ml) for the parent strains K21a, K36,
and K2. The MR/K-HA
activity of the corresponding noncapsulated
variants did not differ
significantly from that of their corresponding
capsulated parent
strains. The capsulated K26 and K50 strains were more
active,
showing minimal MR/K-HA activity at 7.5 × 10
8
CFU; the activity of the corresponding noncapsulated variants
was
similar except for one K26-derived noncapsulated variant
(KPTA
51), which exhibited activity at 7 × 10
7
CFU/ml (
P < 0.01).
Relationship between capsule formation and adhesion and
internalization into epithelial cells.
For each pair of strains,
the percent internalization of capsulated strains by both types of
epithelial cells was significantly lower than that of the noncapsulated
variants (P < 0.01) (Table 2). Likewise, the percent
adhesion to the two types of epithelial cells was significantly lower
for capsulated than noncapsulated strains for each pair (P < 0.02) except K26 and K26/1. Nevertheless, the overall adhesion
values for all capsulated parent strains were significantly lower than
those for the noncapsulated variants (Table
2). It should be noted, however, that
although the magnitude of adhesion of either the noncapsulated or
capsulated strains was in the same range for both types of cell lines,
invasion into T24 bladder epithelial cells was considerably lower than
that into intestinal cells. The host cell tropism was further examined by using two other human cell lines, the embryonic intestinal cell line
INT 407 and the bladder cell line RT112. The invasion of all capsulated
strains and their noncapsulated phase variants in these cell lines was
below the level of detection.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Adhesion to and internalization by epithelial cells of
capsulated parent strains and their corresponding
noncapsulated variantsa
|
|
To further examine the relationship between adhesion, internalization,
and capsulation, three additional noncapsulated phase
variants of each
serotype were obtained. Furthermore, a revertant
capsulated strain
derived from the noncapsulated variant and a
capsule-switched
derivative were used. The amount of capsule formed
by the K2(K36)
recombinant strain was significantly higher than
that formed by the
parent strain (92 ± 10 versus 62 ± 7 µg of
glucuronic
acid/10
9 bacteria,
P < 0.01). The values
of percent adhesion and invasion
for the recombinant K2(K36) were
markedly lower than those for
the parent K2 strain (Fig.
2). All of the three noncapsulated
variants exhibited significantly more extensive invasion into
ileocecal
epithelial cells compared to their corresponding capsulated
parent
strains (Fig.
3). Although the
internalization in bladder
cells was significantly lower than that in
ileocecal cells, there
was a significant difference between the ability
of the noncapsulated
variants to invade bladder epithelial cells
compared to their
corresponding parent strains (data not shown).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2.
Capsule formation, cellular adhesion, and
internalization of the K2 and K36 parent strains and their
capsule-switched derivative. Confluent monolayers of HCT-8 cells were
exposed to K2 (closed box) and K36 (striped box) capsulated parent
strains and their derivative K2(K36) (open box). The amount of
glucuronic acid (micrograms per 109 bacteria), percent
adhesion to, and percent internalization into the cell lines were
estimated as described in Materials and Methods. Data represent mean
values and standard deviations of at least quadruplicate experiments
for each strain. Mean values for the K2 and K36 parent strains were
significantly higher than those for K2(K36) (P > 0.01)
for both the adhesion and internalization assays.
|
|

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 3.
Internalization of noncapsulated variants of
Klebsiella into HCT-8 cells. Relative invasion represents
the percent increase in invasion of three noncapsulated variants (open
boxes) from each of the indicated Klebsiella serotypes
compared to the corresponding capsulated parent strains (=100%; closed
boxes). The hatched box is the relative invasion of the K21a capsulated
revertant strain derived from a noncapsulated variant strain. Percents
invasion of the capsulated parent strains were 0.75, 2.94, 4.55, 3.58, and 2.74 for K26, K36, K50, K2, and K21a, respectively. All values for
the noncapsulated variants are significantly higher (P < 0.01) than those for the corresponding capsulated parent strains.
Data shown represent mean values and standard deviations.
|
|
Bacterial intracellular persistence and replication.
Following
the initial 2-h gentamicin killing period, the number of intracellular
capsulated parent strain and noncapsulated variants of K50 recovered in
the presence of 10 µg of gentamicin per ml did not changed
significantly during 48 h of incubation. Thereafter the number of
intracellular bacteria of the noncapsulated variant declined
significantly, while that of the capsulated bacteria did not change
significantly (Fig. 4).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 4.
Intracellular survival of capsulated parent strain K50
and its noncapsulated variant K50/3. Monolayers of HCT-8 cells were
infected with the indicated K. pneumoniae strains. After
invasion, the medium was replaced with fresh medium containing 10 µg
of gentamicin ml, and the monolayers were lysed at the indicated times
to determine the number of the intracellular bacteria expressed as a
percentage of inoculum. The asterisk denotes a value significantly
different from that obtained after 2 h (P < 0.01). Data shown represent mean values and standard deviations.
|
|
 |
DISCUSSION |
K. pneumoniae, a classic extracellular pathogen, has
been shown to be internalized by nonphagocytic cells (20,
24). In the present study, this ability was found to be markedly
hampered by the presence of capsular material on the bacterial surface. This notion is supported by our findings showing that (i) all of the
noncapsulated variants were internalized in significantly higher
numbers than the corresponding parent strains by both types of
epithelial cells, (ii) a revertant K21a capsulated variant derived from
a noncapsulated strain invaded epithelial cells poorly, and (iii) a
genetically manipulated strain exhibiting a larger capsule and forming
more capsular material invaded the intestinal epithelial cell line
poorly compared to the corresponding parent strain. Although the
isogenic identity of the noncapsulated variants with their parent
strains has not been fully elucidated, it is unlikely that the observed
reduced internalization of the capsulated parent strain is due to
factors other than capsule formation because (i) the DNA patterns as
well as phenotypic behaviors of parents and their corresponding
noncapsulated variants were identical, (ii) even if there is a
hypothetical difference in the genetic background of the noncapsulated
variants derived from a capsulated clone, the probability that such
other hypothetical factors contributed to the difference in their
invasion ability is anticipated to be low because in all cases the
noncapsulated strains behaved similarly with respect to invasion
ability, and (iii) a K21a revertant capsulated strain derived from a
noncapsulated variant exhibited reduced invasion similar to that of the
original parent capsulated strain. A major prerequisite for the
pathogen to invade epithelial cells is its ability to adhere to the
target cells. The results showing that capsulated bacteria which
invaded epithelial cells poorly also adhered significantly less to
these cells is consistent with this notion. The results appear to
suggest that capsule interferes in some manner with the ability of
Klebsiella to adhere to the epithelial cells and
consequently to be internalized by these cells. There may be a
number of mechanisms through which capsule could interfere with
adhesion of Klebsiella to epithelial cells. One mechanism
may be a masking effect in which the adhesins on the bacterial surface
are not accessible for binding to their cognate receptors on epithelial cells.
Another mechanism may involve interference of capsule precursors or
regulatory elements that precede biosynthesis or secretion with the
ability of the capsulated strain to assemble type 1 fimbrial subunits
into mature fimbriae on the bacterial surface (22). This may
be the case for the capsulated parent strains K21a and K50 because
their corresponding noncapsulated variants K21a/3 and K50/3 exhibited
potent type 1 fimbrial activity (Table 1). It has been shown that 48-h
broth cultures after several passages provide the best conditions for
the expression of both type 1 and type 3 fimbriae (31). In
the invasion assay, we used bacteria grown in Luria broth for 2 h.
When Luria broth was inoculated from passaged 48-h cultures, the MSHA
and MR/K-HA activities per mass unit after a 2-h incubation were the
same as that of the inoculum, suggesting that the culture conditions
for bacteria used in the invasion assay were permissible for the
expression of both MSHA and MR/K-HA. Adhesion via type 1 fimbriae has
been shown recently to promote invasion of Citrobacter spp.
into epithelial cells (N. Daryab, C. Wass, J. Badger, K. S. Kim,
and T. A. Oelschlaeger, Abstr. 99th Gen. Meet. Am. Soc.
Microbiol., abstr. B/D 176, p. 63, 1999). Capsule may also modulate the
transcription of the recently described CF29K adhesin of
K. pneumoniae (19). It is also
possible that additional adhesins not affected by capsule formation
play a role in the invasion process. In this regard, the relatively
high activities of both the capsulated and noncapsulated phases of
serotype K26 may be mediated by such putative adhesins.
Taken together, the results suggest that capsule formation by K. pneumoniae interferes with the expression of a number of adhesins
and thus impairs the ability of the bacteria to be internalized by
nonphagocytic cells. Furthermore, it is tempting to speculate on the
dual role of the capsule in virulence in the context of the site of
infection. In the phagocyte-poor environment of mucosal surfaces,
capsule is deleterious to the infectious process irrespective of its
chemical structure. This notion is supported by the fact that
epithelial cells are not known to express a lectin such as the mannose
receptor that recognizes any of the capsular serotypes of K. pneumoniae. In the phagocyte-rich environment of deep tissues such
as the lung, the cleansing mechanisms are ineffective and clearance of
invading bacteria is dependent on phagocytosis. In this regard,
some CPS (e.g., containing D-mannose or dirhamnose repeating units) are deleterious to the infectious process because they
are recognized by the mannose receptor on the phagocytic cells
(25).
Adhesion by itself is probably not enough to enable the pathogen to
invade nonphagocytic cells. Entry of bacteria into animal cells
generally has been found to require the coexpression of multiple
components and to involve signal transduction via receptors distinct
from those required for adhesion (8, 13, 14). Klebsiella species also seem to require distinct components
to be internalized by epithelial cells because internalization of the
bacteria by mature intestinal cells was much greater than internalization by embryonic intestinal cells or bladder epithelial cells. Previous studies have also shown marked differences in the
invasion of a urinary isolate of a K. pneumoniae strain into various cell lines (24). Obviously, various epithelial cells may lack one or more of the components required for the internalization of the different Klebsiella strains. At this point, the
possibility that the observed enhanced internalization of
Klebsiella by the HCT-8 ileocecal cells is cell line
specific rather than tropism for mature intestinal cells cannot be excluded.
Invasion of nonphagocytic cells by bacteria is now considered to be a
major virulence factor in the infectious process (18). While
this notion is well documented for intracellular pathogens such as
Yersinia spp., Listeria spp.,
Salmonella spp., and Shigella spp., it is less
clear for those pathogens whose lifestyle is primarily extracellular.
Nevertheless, the list of classic extracellular pathogens that are
capable of being internalized by nonphagocytic cells is growing. We
have shown that following invasion the Klebsiella organisms
persist for at least 72 h, albeit in small numbers. Internalization of bacterial pathogens by nonphagocytic cells such as
epithelial cells probably enables the bacteria to escape the effects of
deleterious agents such as antibodies and antibiotics. Recently it was
suggested that in the case of Streptococcus pyogenes, internalization may also lead to asymptomatic carriage (23). It has been suggested that although Klebsiella colonizes
asymptomatically a number of body sites, the main reservoir for severe
symptomatic infections is the large bowel (7, 34). The
observation, therefore, that the tested Klebsiella serotypes
invade intestinal cells better than bladder cells supports the notion
that K. pneumoniae surviving within epithelial
cells may serve as a critical reservoir from which reinfection of the
host can take place and capsule formation may modulate this process.
Thus, although Klebsiella strains are more pathogenic in the
urinary tract, the latter is not the habitat of this or in fact of any
other bacteria.
 |
ACKNOWLEDGMENTS |
This work was supported by Deutsche Forschungsgemeinschaft grants
SA 730/1-1 and SA730/1-2.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medical Microbiology and Virology, University of Kiel, Brunswiker Str. 4, 24105 Kiel, Germany. Phone: 494315973316. Fax: 494315973296. E-mail: sahly{at}medmicrobio.uni-kiel.de.
Editor:
V. J. DiRita
 |
REFERENCES |
| 1.
|
Blumenkrantz, N., and G. Asboe-Hansen.
1973.
New method for quantitative determination of uronic acids.
Anal. Biochem.
54:484-489[CrossRef][Medline].
|
| 2.
|
Campbell, W.,
E. Hendrix,
S. J. Cryz, and A. Cross.
1996.
Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma.
Clin. Infect. Dis.
23:179-181[Medline].
|
| 3.
|
Casewell, M., and H. G. Talsania.
1979.
Predominance of certain Klebsiella capsular types in hospitals in the United Kingdom.
J. Infect.
1:77-79.
|
| 4.
|
Cryz, S. J.,
E. Fürer, and R. Germanier.
1984.
Experimental Klebsiella pneumoniae burn wound sepsis: role of capsular polysaccharide.
Infect. Immun.
43:440-441[Abstract/Free Full Text].
|
| 5.
|
Cryz, S. J., Jr.,
E. Fürer, and R. Germanier.
1985.
Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans.
J. Infect. Dis.
151:665-671[Medline].
|
| 6.
|
Cryz, S. J.,
P. M. Mortimer,
V. Mansfield, and R. Germanier.
1986.
Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development.
J. Clin. Microbiol.
23:687-690[Abstract/Free Full Text].
|
| 7.
|
De Champ, C.,
M. P. Sauvant,
C. Chanal,
D. Sirot,
N. Gazuy,
R. Malhuret,
J. C. Baguet, and J. Sirot.
1989.
Prospective survey of colonization and infection caused by extended spectrum-beta-lactamase-producing members of the family Enterobacteriaceae in intensive care units.
J. Clin. Microbiol.
27:2887-2890[Abstract/Free Full Text].
|
| 8.
|
De Vries, F. P.,
A. van der Ende,
J. P. M. van Putten, and J. Dankert.
1996.
Invasion of primary nasopharyngeal epithelial cells by Neisseria meningitidis is controlled by phase variation of multiple surface antigens.
Infect. Immun.
64:2998-3006[Abstract].
|
| 9.
|
Domenico, P.,
W. G. Johanson, and D. C. Straus.
1982.
Lobar pneumonia in rats produced by clinical isolates of Klebsiella pneumoniae.
Infect. Immun.
37:327-335[Abstract/Free Full Text].
|
| 10.
|
Domenico, P.,
D. R. Landolphi, and B. A. Cunha.
1991.
Reduction of capsular polysaccharide and potentiation of aminoglycoside inhibition in Gram-negative bacteria by bismuth salicylate.
J. Antimicrob. Chemother.
28:801-810[Abstract/Free Full Text].
|
| 11.
|
Domenico, P.,
S. Schwartz, and B. A. Cunha.
1989.
Reduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate.
Infect. Immun.
57:3778-3782[Abstract/Free Full Text].
|
| 12.
|
Domenico, P.,
J. M. Tomas,
S. Merino,
X. Rubires, and B. A. Cunha.
1999.
Surface antigen exposure by bismuth dimercaprol suppression of Klebsiella pneumoniae capsular polysaccharide.
Infect. Immun.
67:664-669[Abstract/Free Full Text].
|
| 13.
|
Donnenberg, M. S.
1999.
Interactions between enteropathogenic Escherichia coli and epithelial cells.
Clin. Infect. Dis.
28:451-455[Medline].
|
| 14.
|
Donnenberg, M. S.,
J. K. Kaper, and B. Finlay.
1997.
Interaction between enteropathogenic Escherichia coli and host epithelial cells.
Trends Microbiol.
5:109-114[CrossRef][Medline].
|
| 15.
|
Dutton, G. G. S.,
S. K. Ng,
L. A. S. Parolis, and H. Parolis.
1989.
A re-investigation of the structure of the capsular polysaccharides of Klebsiella K10.
Carbohydr. Res.
193:147-155[CrossRef][Medline].
|
| 16.
|
Edelman, R.,
D. N. Taylor,
S. S. Wasserman,
J. B. McClain,
A. S. Cross,
J. C. Sadoff,
J. U. Que, and S. J. Cryz.
1994.
Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously.
Vaccine
12:1288-1294[CrossRef][Medline].
|
| 17.
|
Ehrenwort, L., and H. Baer.
1956.
The pathogenicity of Klebsiella pneumoniae for mice: the relationship to the quantity and rate of production of type-specific capsular polysaccharide.
J. Bacteriol.
72:713-717[Free Full Text].
|
| 18.
|
Falkow, S.
1997.
Perspectives series: host/pathogen interactions. Invasion and intracellular sorting of bacteria: searching for bacterial genes expressed during host/pathogen interactions.
J. Clin. Investig.
100:239-243[Medline].
|
| 19.
|
Favre-Bonte, S.,
B. Joly, and C. Forestier.
1999.
Consequences of reduction of Klebsiella pneumoniae capsule expression on interaction of this bacterium with epithelial cells.
Infect. Immun.
67:554-561[Abstract/Free Full Text].
|
| 20.
|
Fumagalli, O.,
B. Tall,
C. Schipper, and T. A. Oelschlaeger.
1997.
N-glycosylated proteins are involved in efficient internalization of Klebsiella pneumoniae by cultured human epithelial cells.
Infect. Immun.
65:4445-4451[Abstract].
|
| 21.
|
Highsmith, A. K., and W. R. Jarvis.
1985.
Klebsiella pneumoniae: selected virulence factors that contribute to pathogenicity.
Infect. Control
6:75-77[Medline].
|
| 22.
|
Matatov, R.,
I. Ofek,
E. Skutelsky,
I. Schechter,
R. Perry,
R. Podschun,
H. Sahly,
K. Thankavel,
S. N. Abraham, and J. Goldhar.
1999.
Inability of encapsulated Klebsiella pneumoniae to assemble functional type 1 fimbriae on their surface.
FEMS Microbiol. Lett.
179:123-130[CrossRef][Medline].
|
| 23.
|
Neeman, R.,
N. Keller,
A. Brazilai,
Z. Korenman, and S. Sela.
1998.
Prevention of internalisation-associated gene, prtF1, among persisting group-A Streptococcus strains isolated from asymptomatic carriers.
Lancet
352:1974-1977[CrossRef][Medline].
|
| 24.
|
Oelschlaeger, T., and B. Tall.
1997.
Invasion of cultured human epithelial cells by Klebsiella pneumoniae isolated from the urinary tract.
Infect. Immun.
65:2950-2958[Abstract].
|
| 25.
|
Ofek, I.,
J. Goldhar,
Y. Keisari, and N. Sharon.
1995.
Nonopsonic phagocytosis of microorganisms.
Annu. Rev. Microbiol.
49:239-276[CrossRef][Medline].
|
| 26.
|
Ofek, I.,
K. Kabha,
A. Athamna,
G. Frankel,
D. J. Wozniak,
L. D. Hasty, and E. D. Ohman.
1993.
Genetic exchange of determinants for capsular polysaccharide biosynthesis between Klebsiella pneumoniae strains expressing serotypes K2 and K21a.
Infect. Immun.
61:4208-4216[Abstract/Free Full Text].
|
| 27.
|
Ørskov, I., and M. A. Fife-Asbury.
1979.
New Klebsiella capsular antigen, K82, and the deletion of five of those previously assigned.
Int. J. Syst. Bacteriol.
27:386-387.
|
| 28.
|
Podschun, R.
1990.
Phenotypic properties of Klebsiella pneumoniae and K. oxytoca isolated from different sources.
Zentbl. Hyg.
189:527-535.
|
| 29.
|
Podschun, R.,
P. Heineken,
U. Ullmann, and H. G. Sonntag.
1986.
Comparative investigations of Klebsiella species of clinical origin: plasmid patterns, biochemical reactions, antibiotic resistances and serotypes.
Zentbl. Bakteriol. Hyg. A
262:335-345.
|
| 30.
|
Podschun, R.,
I. Penner, and U. Ullmann.
1992.
Interaction of Klebsiella capsular type 7 with human polymorphonuclear leucocytes.
Microb. Pathog.
13:371-379[CrossRef][Medline].
|
| 31.
|
Podschun, R., and H. Sahly.
1991.
Hemagglutinins of Klebsiella pneumoniae and Klebsiella oxytoca isolated from different sources.
Zentbl. Hyg.
191:46-52.
|
| 32.
|
Podschun, R., and U. Ullmann.
1993.
Bacteriocin typing of environmental Klebsiella isolates.
Zentbl. Hyg.
195:22-26.
|
| 33.
|
Podschun, R., and U. Ullmann.
1992.
Klebsiella capsular type K7 in relation to toxicity, susceptibility to phagocytosis and resistance to serum.
J. Med. Microbiol.
36:250-254[Abstract/Free Full Text].
|
| 34.
|
Podschun, R., and U. Ullmann.
1998.
Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors.
Clin. Microbiol. Rev.
11:589-603[Abstract/Free Full Text].
|
| 35.
|
Riser, E., and P. Noone.
1981.
Klebsiella capsular type versus site of isolation.
J. Clin. Pathol.
34:552-555[Abstract/Free Full Text].
|
| 36.
|
Sahly, H., and R. Podschun.
1997.
Clinical, bacteriological, and serological aspects of Klebsiella infections and their spondylarthopathic sequelae.
Clin. Diagn. Lab. Immunol.
4:393-399[Medline].
|
| 37.
|
Sahly, H.,
R. Podschun,
R. Sass,
B. Bröcker,
W. L. Gross,
J. Kekow, and U. Ullmann.
1994.
Serum antibodies to the 77 Klebsiella capsular types in ankylosing spondylitis.
Arthritis Rheum.
37:754-759[Medline].
|
| 38.
|
Simoons-Smit, A. M.,
A. M. J. J. Verweij-van Vught,
I. Y. R. Kanis, and D. M. MacLaren.
1985.
Chemiluminescence of human leucocytes stimulated by clinical isolates of Klebsiella.
J. Med. Microbiol.
19:333-338[Abstract/Free Full Text].
|
| 39.
|
Simoons-Smit, A. M.,
A. M. J. J. Verweij-van Vught, and D. M. MacLaren.
1986.
The role of K antigens as virulence factors in Klebsiella.
J. Med. Microbiol.
21:133-137[Abstract/Free Full Text].
|
| 40.
|
Weller, T. M. A.,
F. M. Mackenzie, and K. J. Forbes.
1997.
Molecular epidemiology of a large outbreak of multiresistant Klebsiella pneumoniae.
J. Med. Microbiol.
46:921-926[Free Full Text].
|
| 41.
|
Williams, P.,
P. A. Lambert,
M. R. W. Brown, and R. J. Jones.
1983.
The role of the O and K antigens in determining the resistance of Klebsiella aerogenes to serum killing and phagocytosis.
J. Gen. Microbiol.
129:2181-2191[Abstract/Free Full Text].
|
Infection and Immunity, December 2000, p. 6744-6749, Vol. 68, No. 12
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wu, M.-F., Yang, C.-Y., Lin, T.-L., Wang, J.-T., Yang, F.-L., Wu, S.-H., Hu, B.-S., Chou, T.-Y., Tsai, M.-D., Lin, C.-H., Hsieh, S.-L.
(2009). Humoral Immunity against Capsule Polysaccharide Protects the Host from magA+ Klebsiella pneumoniae-Induced Lethal Disease by Evading Toll-Like Receptor 4 Signaling. Infect. Immun.
77: 615-621
[Abstract]
[Full Text]
-
Struve, C., Bojer, M., Krogfelt, K. A.
(2008). Characterization of Klebsiella pneumoniae Type 1 Fimbriae by Detection of Phase Variation during Colonization and Infection and Impact on Virulence. Infect. Immun.
76: 4055-4065
[Abstract]
[Full Text]
-
Sahly, H., Navon-Venezia, S., Roesler, L., Hay, A., Carmeli, Y., Podschun, R., Hennequin, C., Forestier, C., Ofek, I.
(2008). Extended-Spectrum {beta}-Lactamase Production Is Associated with an Increase in Cell Invasion and Expression of Fimbrial Adhesins in Klebsiella pneumoniae. Antimicrob. Agents Chemother.
52: 3029-3034
[Abstract]
[Full Text]
-
Rosen, D. A., Pinkner, J. S., Jones, J. M., Walker, J. N., Clegg, S., Hultgren, S. J.
(2008). Utilization of an Intracellular Bacterial Community Pathway in Klebsiella pneumoniae Urinary Tract Infection and the Effects of FimK on Type 1 Pilus Expression. Infect. Immun.
76: 3337-3345
[Abstract]
[Full Text]
-
Sahly, H., Keisari, Y., Crouch, E., Sharon, N., Ofek, I.
(2008). Recognition of Bacterial Surface Polysaccharides by Lectins of the Innate Immune System and Its Contribution to Defense against Infection: the Case of Pulmonary Pathogens. Infect. Immun.
76: 1322-1332
[Full Text]
-
Scorpio, A., Chabot, D. J., Day, W. A., O'Brien, D. K., Vietri, N. J., Itoh, Y., Mohamadzadeh, M., Friedlander, A. M.
(2007). Poly-{gamma}-Glutamate Capsule-Degrading Enzyme Treatment Enhances Phagocytosis and Killing of Encapsulated Bacillus anthracis. Antimicrob. Agents Chemother.
51: 215-222
[Abstract]
[Full Text]
-
Andrian, E., Grenier, D., Rouabhia, M.
(2006). Porphyromonas gingivalis-Epithelial Cell Interactions in Periodontitis. JDR
85: 392-403
[Abstract]
[Full Text]
-
Kostina, E., Ofek, I., Crouch, E., Friedman, R., Sirota, L., Klinger, G., Sahly, H., Keisari, Y.
(2005). Noncapsulated Klebsiella pneumoniae Bearing Mannose-Containing O Antigens Is Rapidly Eradicated from Mouse Lung and Triggers Cytokine Production by Macrophages following Opsonization with Surfactant Protein D. Infect. Immun.
73: 8282-8290
[Abstract]
[Full Text]
-
Schembri, M. A., Blom, J., Krogfelt, K. A., Klemm, P.
(2005). Capsule and Fimbria Interaction in Klebsiella pneumoniae. Infect. Immun.
73: 4626-4633
[Abstract]
[Full Text]
-
Schwan, W. R., Beck, M. T., Hultgren, S. J., Pinkner, J., Woolever, N. L., Larson, T.
(2005). Down-Regulation of the kps Region 1 Capsular Assembly Operon following Attachment of Escherichia coli Type 1 Fimbriae to D-Mannose Receptors. Infect. Immun.
73: 1226-1231
[Abstract]
[Full Text]
-
Schembri, M. A., Dalsgaard, D., Klemm, P.
(2004). Capsule Shields the Function of Short Bacterial Adhesins. J. Bacteriol.
186: 1249-1257
[Abstract]
[Full Text]
-
Sahly, H., Ofek, I., Podschun, R., Brade, H., He, Y., Ullmann, U., Crouch, E.
(2002). Surfactant Protein D Binds Selectively to Klebsiella pneumoniae Lipopolysaccharides Containing Mannose-Rich O-Antigens. J. Immunol.
169: 3267-3274
[Abstract]
[Full Text]
-
Cortes, G., Alvarez, D., Saus, C., Alberti, S.
(2002). Role of Lung Epithelial Cells in Defense against Klebsiella pneumoniae Pneumonia. Infect. Immun.
70: 1075-1080
[Abstract]
[Full Text]
-
Swiatlo, E., Champlin, F. R., Holman, S. C., Wilson, W. W., Watt, J. M.
(2002). Contribution of Choline-Binding Proteins to Cell Surface Properties of Streptococcus pneumoniae. Infect. Immun.
70: 412-415
[Abstract]
[Full Text]